Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery
Launched by TECHNISCHE UNIVERSITÄT DRESDEN · Dec 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new surgical assistance system that uses advanced technology to help doctors perform robot-assisted surgery for patients with rectal cancer. The goal is to see if this system, which relies on image recognition to guide the surgeon, is effective and safe for use in real surgeries. The study will also look at how well this new system works in terms of cancer outcomes.
To participate in this trial, you need to be an adult aged 65 years or older who has been diagnosed with rectal cancer and is scheduled for robot-assisted surgery. You should have normal urinary and bowel function before the surgery and be able to give consent to participate. If you have had certain other cancers in the last five years or specific previous abdominal surgeries, you may not be eligible. If you join the trial, you can expect to receive standard care for your rectal cancer, with the added benefit of this innovative surgical assistance system being used during your procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with rectal cancer scheduled for robot-assisted rectal resection
- • Intact preoperative urogenital/rectal function
- • Full capability of consent
- Exclusion Criteria:
- • Previous/Second malignant disease \<5 years before diagnosis of rectal cancer
- • Previous abdominal surgery, except for appendectomy, cholecystectomy or Cesarean section
About Technische Universität Dresden
Technische Universität Dresden (TU Dresden) is a leading research institution in Germany, renowned for its commitment to advancing scientific knowledge and innovation across various disciplines, including medicine and healthcare. As a clinical trial sponsor, TU Dresden leverages its cutting-edge research facilities and interdisciplinary expertise to facilitate the development of novel therapeutic interventions and improve patient outcomes. The university fosters collaboration among academic, clinical, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in the conduct of clinical research. Through its dedication to excellence and research-driven initiatives, TU Dresden plays a pivotal role in translating scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dresden, Saxony, Germany
Patients applied
Trial Officials
Marius Distler, Prof. Dr.
Principal Investigator
University Hospital Carl Gustav Carus Dresden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials